Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer

J Clin Oncol. 2008 Apr 10;26(11):1907-8; author reply 1908-9. doi: 10.1200/JCO.2007.15.9640.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Dehydration / chemically induced
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Diarrhea / chemically induced
  • Drug Administration Schedule
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives
  • Humans
  • Randomized Controlled Trials as Topic
  • Vomiting / chemically induced

Substances

  • Deoxycytidine
  • Fluorouracil
  • Camptothecin

Supplementary concepts

  • capecitabine-irinotecan combination